Bone Biologics Corporation
BBLG · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $5,008 | $2,248 | $15,278 | $16,661 |
| - Cash | $6,049 | $6,640 | $2,747 | $3,325 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$1,041 | -$4,393 | $12,532 | $13,335 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $49 | -$748 | -$1,017 | -$1,522 |
| % Margin | – | – | – | – |
| Net Income | -$667 | -$741 | -$1,017 | -$1,522 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.37 | -1.33 | -0.32 | -0.48 |
| % Growth | 72.2% | -315.6% | 33.3% | – |
| Operating Cash Flow | -$591 | -$459 | -$926 | -$1,353 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$591 | -$459 | -$926 | -$1,353 |